+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID05671718

Bring BPaL2Me Trial Comparing Nurse-Led Rifampicin-Resistant Tuberculosis Treatment in Primary Care Clinics to Physician-Led Hospital-Based Outpatient Treatment A Cluster Randomized Non-Inferiority Study

Led by Johns Hopkins University · Updated on 2026-10-26

2944

Participants Needed

5

Research Sites

130 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating nurse-led treatment for rifampicin-resistant tuberculosis RR-TB in primary care clinics compared to standard physician-led treatment at district hospitals in South Africa. This multi-site, cluster randomized trial aims to assess treatment outcomes, safety, and patient costs over five years. The study also explores how this approach affects HIV co-infected patients and addresses the high costs and access barriers associated with hospital-based care. Participants will receive RR-TB treatment either through nurses available once or twice weekly at primary care clinics or through physicians at hospital outpatient sites. Nurse availability will rotate between clinics to mirror physician duties. The trial will compare the two approaches for treatment success, safety events, and catastrophic costs exceeding 20% of household income. Secondary goals include evaluating timing for treatment initiation, symptom resolution, provider adherence, and cost-effectiveness. During the study, participants will be closely monitored through laboratory tests, clinical assessments, and cost tracking over 12 months. Key outcomes include treatment success at six months, severe adverse events within a year, and patient cost burdens. The study involves regular evaluations of dosing adjustments and HIV-related treatment milestones. Participation spans from initial diagnosis through a year of follow-up, with blinded analysis and safety reviews to ensure data integrity.

CONDITIONS

Brief Title

Bring BPaL2Me Trial Comparing Nurse-Led RR-TB Treatment to Physician-Led RR-TB Treatment

Research Team

K

Kelly Lowensen, MSN, RN

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here